Body

miR-205 overexpression can be responsible for breast cancer

Over the past couple of years research into miRNAs has become increasingly diversified and attracted a great number of research articles across genetics and medicine. This should hardly come as a surprise to any scientist in the field, especially since it has become clear that miRNAs, a recently discovered class of non-coding RNAS, are represented in nearly all cellular functions and molecular pathways.

Liver mitochondria improve, increase after chronic alcohol feeding in mice

Scientists at the Keck School of Medicine of the University of Southern California (USC) have found evidence that liver mitochondria in mice adapt to become better metabolizers of alcohol and increase in number after chronic exposure, which may raise the potential for free radical damage associated with aging and cancer over time.

Evolution of flying bat clue to cancer and viruses

The genes of long-living and virus resistant bats may provide clues to the future treatment and prevention of infectious diseases and cancer in people, researchers have found.

Published in the journal Science, the research provides an insight into the evolution of bat's flight, resistance to viruses and relatively long life.

To outsmart malarial drug resistance, research team develops new whole-plant strategy

AMHERST, Mass. – Malaria brings misery and death to millions in the developing world each year, and fighting it keeps medical researchers up at night because the mosquito-borne parasite Plasmodium falciparum, which causes the deadliest form of the disease, has developed resistance to every drug thrown at it. Resistance has cut short the useful life of nearly every therapy tried so far, experts say.

Microevolutionary analysis of Clostridium difficile genomes to investigate transmission

Over recent years, hospital-acquired Clostridium difficile infections have been a significant problem in UK hospitals and globally. There have been concerns that infections may be due to transmission between symptomatic patients, either directly, or indirectly via hospital staff; these concerns were strengthened when enhanced infection control was introduced in England in 2007, and the incidence of C. difficile infection declined.

Newborn baby screening for fragile X syndrome

A study into newborn screening for fragile X syndrome (FXS) demonstrates that testing for mutations in the gene FMR1 can be done on a large scale. The research, published in BioMed Central's open access journal Genome Medicine, shows that the number of carrier babies who carry the form of the gene known as the "premutation" is higher than previously estimated.

Genetic defect causing fragile X-related disorders more common than thought

A single genetic defect on the X chromosome that can result in a wide array of conditions — from learning and emotional difficulties to primary ovarian insufficiency in women and tremors in middle-aged men — occurs at a much greater frequency than previously thought, research led by the UC Davis MIND Institute has found.

Cancer diagnosis later in life poses significant risk to offspring

Relatives of family members diagnosed with cancer are still at risk of the disease even if the diagnosis came at an older age, suggests a paper published on bmj.com today.

It is known that early onset cancer cases carry more hereditary risk than late onset cases, but little is known about whether any familial component exists in cancer at a very old age.

Extending steroid treatment does not benefit children with hard-to-treat kidney disease

Highlights

Research reveals new drug target urgently needed for tuberculosis therapy

One third of the world is infected with the bacterium that causes tuberculosis (TB), a disease that is increasingly difficult to treat because of wide spread resistance to available drugs. Researchers from the Institute of Pharmacology and Structural Biology (CNRS, Université de Toulouse) in Toulouse (France) have identified a fresh target to develop new drugs for TB. The study, published in the Open Access journal PLOS Pathogens, shows why the target will be important in developing new TB treatments.

Genetic differences may influence sensitivity to pain, according to new study

The study, published in PLOS Genetics on 20 December, adds to growing evidence that particular genes are involved in chronic pain and highlights this pathway as a potential target for more effective pain relief treatments for patients.

The collaborative study between King's, Pfizer Ltd and the Beijing Genomics Institute (BGI), used a new method to study and compare DNA, called 'exome sequencing', to identify genetic variations relating to pain sensitivity.

New whole plant therapy shows promise as an effective and economical treatment for malaria

Worcester, Mass. – In the worldwide battle to curtail malaria, one of the most prevalent and deadly infectious diseases of the developing world, drug after drug has fallen by the wayside as the malaria parasite has become resistant to it. Only artemisinin, derived from the sweet wormwood plant, Artemisia annua, remains as an effective treatment, but it is expensive to produce (particularly when combined with other antimalarial medications to make it less prone to resistance) and is frequently in short supply.

BGI reports the new findings reveal blood pressure dugs may treat chronic pain

December 20, 2012, Shenzhen, China – An international team, comprised King's College London, Pfizer, BGI and other organizations, has explored the genetic variation related with pain sensitivity in the normal population, revealing some existing discovery that treatments for high blood pressure may also be used to treat chronic pain in the future. The latest study was published online in the international journal PLoS Genetics.

Transplanted genetically-modified adipose cells offer potential therapy for liver diseases

Putnam Valley, NY. (Dec. 20, 2012) – Using mesenchymal stromal cells derived from adipose (fat) tissues, genetically modified to express a bioluminescent marker, researchers in Italy have tracked cells after transplantation. The cells were followed from their injection into the spleen of mice modeling liver disease, to their characterization as "hepatic precursors," and to their subsequent migration through the spleen before engrafting at regenerating sites in the liver by bioluminescent imaging.

WCS applauds Dept. of Interior plan balancing conservation and energy development in NPR-A

The Wildlife Conservation Society (WCS) lauded U.S. Secretary of the Interior Ken Salazars announcement of a final management plan for the National Petroleum Reserve-Alaska (NPR-A) that balances wildlife conservation and energy development in the biggest public landscape in the country. The Integrated Activity Plan and Final Environmental Impact Statement (Final IAP/EIS) issued today by the Bureau of Land Management is the first comprehensive land management plan ever developed for the NPR-A.